Search

Your search keyword '"ANILIDES"' showing total 9,965 results

Search Constraints

Start Over You searched for: Descriptor "ANILIDES" Remove constraint Descriptor: "ANILIDES"
9,965 results on '"ANILIDES"'

Search Results

1. A phase II study of cabozantinib and pembrolizumab in advanced gastric/gastroesophageal adenocarcinomas resistant or refractory to immune checkpoint inhibitors.

2. Assessing patient burden and benefit: A decade of cabozantinib clinical trials

3. A Phase 1 Study of Cabozantinib and Trifluridine/Tipiracil in Metastatic Colorectal Adenocarcinoma

4. Benzo[ d ]oxazoles from Anilides by N -Deprotonation– O -S N Ar Cyclization.

5. Tailoring photocatalysts to modulate oxidative potential of anilides enhances para-selective electrochemical hydroxylation.

6. Construction of N-heterocycles through group 9 (Co, Rh, Ir) metal-catalyzed C-H activation: utilizing alkynes and olefins as coupling partners.

7. Effects of the structure of primary nitroalkanes and reaction conditions on the selectivity of acylamination of arenes in polyphosphoric acid.

8. Copper‐Promoted Oxidative Amide‐Assisted Radical Selenylation of Anilides and N‐Arylsulfonamides with Diselenides.

9. Synthesis, structure and stereodynamics of atropisomeric N-chloroamides.

10. Therapeutic efficacy of FASN inhibition in preclinical models of HCC

11. First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors

12. Control of atropoisomerism: an access to valuable compounds.

13. Synthesis of Unsymmetrically Substituted Succinic Acid Diamides Containing a Pharmacophoric 2-Aminopyrimidine Fragment as Potential Protein Kinase Inhibitors.

14. Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child-Pugh B liver function at study week 8: a retrospective analysis of the CELESTIAL randomised controlled trial.

15. Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade

16. Clinical Activity of Single-Agent Cabozantinib (XL184), a Multi-receptor Tyrosine Kinase Inhibitor, in Patients with Refractory Soft-Tissue Sarcomas

17. aPC/PAR1 confers endothelial anti-apoptotic activity via a discrete, β-arrestin-2–mediated SphK1-S1PR1-Akt signaling axis

18. Chiral vicinal diamines as promising ligands in Pd-catalyzed reductive Heck type cyclizations.

19. Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma

20. Ruthenium‐Catalyzed Aminocarbonylation with Isocyanates Through Weak Coordinating Groups.

21. Photoelectrocatalytic C–H amination of arenes.

22. Alpelisib combination treatment as novel targeted therapy against hepatocellular carcinoma

23. Conformational dynamics of androgen receptors bound to agonists and antagonists

24. Synthesis of Anilides by Aminolysis of Unactivated Esters using MnCl2 in Combination with strong Bases as Catalyst.

25. Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular Carcinoma

26. Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial.

27. Comparative Efficacy of Cabozantinib and Regorafenib for Advanced Hepatocellular Carcinoma

28. Randomized Phase II Trial and Tumor Mutational Spectrum Analysis from Cabozantinib versus Chemotherapy in Metastatic Uveal Melanoma (Alliance A091201)

29. The microtubule regulator ringer functions downstream from the RNA repair/splicing pathway to promote axon regeneration.

30. Efficacy and safety of direct-acting antiviral agents for HCV in mild-to-moderate chronic kidney disease

31. Axial Chirality in Alkylidene‐Cyclic Molecules.

32. Rare basal cell metastasis of a basal-squamous skin collision tumour to the lung and axillary lymph node

33. Structural Dynamics of Agonist and Antagonist Binding to the Androgen Receptor

34. Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma

35. Patient-reported symptoms during and after direct-acting antiviral therapies for chronic hepatitis C: The PROP UP study

36. Loss of Primary Cilia Drives Switching from Hedgehog to Ras/MAPK Pathway in Resistant Basal Cell Carcinoma

37. A CK1α Activator Penetrates the Brain and Shows Efficacy Against Drug-resistant Metastatic Medulloblastoma

38. Positive allosteric modulation of the α7 nicotinic acetylcholine receptor as a treatment for cognitive deficits after traumatic brain injury

39. Diversity in the genome of Aegilops tauschii , a wild wheat relative, to generate Fe-biofortified and Fe-deficiency-tolerant wheat.

40. Estimating the quantity of substandard and falsified medical products purchased online.

41. A systematic UHPLC Q-ToF MS approach for the characterization of bioactive compounds from freeze-dried red goji berries (L. barbarum L.) grown in Serbia: Phenolic compounds and phenylamides.

42. Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma.

43. Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma

44. Kartogenin Enhances Collagen Organization and Mechanical Strength of the Repaired Enthesis in a Murine Model of Rotator Cuff Repair

45. Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma

46. Biosynthesis of thiocarboxylic acid-containing natural products.

47. E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast Cancer

48. Effect of pH on the Transformation of a New Readymix Formulation of the Herbicides Bispyribac Sodium and Metamifop in Water.

49. Guidelines of care for the management of basal cell carcinoma

50. Guidelines of care for the management of basal cell carcinoma.

Catalog

Books, media, physical & digital resources